Chlamydia pneumoniae, a common bacterium known for causing pneumonia and sinus infections, has been found to potentially exacerbate Alzheimer's disease, according to a groundbreaking study from Cedars-Sinai. The research, published in Nature Communications, reveals that this bacterium can significantly contribute to the progression of Alzheimer's, opening up new avenues for treatment and early intervention.
The study, led by Maya Koronyo-Hamaoui, PhD, a professor of Neurosurgery, Neurology, and Biomedical Sciences at Cedars-Sinai Health Sciences University, utilized advanced imaging, genetic testing, and protein analysis to examine retinal tissue from 104 individuals, including those with normal cognition, mild cognitive impairment, and Alzheimer's disease. The findings were striking: Chlamydia pneumoniae was detected at significantly higher levels in the retinas and brains of individuals with Alzheimer's disease compared to those with normal cognition.
The correlation between bacterial levels and the severity of brain changes and cognitive decline was evident. Individuals carrying the APOE4 gene variant, a known risk factor for Alzheimer's, were more likely to have higher levels of the bacterium. This discovery suggests a potential link between bacterial infection, inflammation, and neurodegeneration, with the eye serving as a surrogate for the brain.
The study further demonstrated that Chlamydia pneumoniae infection in human neurons and laboratory mice with Alzheimer's disease led to increased inflammation, nerve cell death, and cognitive decline. The infection also triggered the production of amyloid-beta, the protein associated with Alzheimer's disease. These findings highlight the potential of targeting the infection-inflammation axis as a novel treatment strategy for Alzheimer's.
Timothy Crother, PhD, co-corresponding author of the study, emphasized the significance of these findings, stating that they raise the possibility of using targeted interventions to treat Alzheimer's. The research also supports the idea of using retinal imaging as a non-invasive method to diagnose and monitor the disease, offering a promising avenue for early detection and intervention.
This study's groundbreaking insights into the role of Chlamydia pneumoniae in Alzheimer's disease open up exciting possibilities for future research and treatment, emphasizing the importance of further exploration in this field.
